Laura McBride

Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma

Paul G. Richardson, Constantine Mitsiades, Kathleen Colson et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 191 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib

Paul G. Richardson, David S. Siegel, Rachid Baz et al. · Blood · 2012 · 161 citations · Full text

Medicine, Oncology, Pharmacology +15

A Phase 1/2 Multi-Center, Randomized, Open Label Dose Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of Pomalidomide Alone or in Combination with Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma Who Have Received Prior Treatment That Includes Lenalidomide and Bortezomib.

Paul Richardson, David S. Siegel, Rachid Baz et al. · Blood · 2009 · 39 citations

Medicine, Pharmacology, Pharmacotherapy +15

Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma

David H. Vesole, Elizabeth Bilotti, Joshua Richter et al. · British Journal of Haematology · 2015 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Dextromethorphan ameliorates effects of neonatal hypoxia on brain morphology and seizure threshold in rats

Nirupama Laroia, Laura McBride, Raymond B. Baggs et al. · Developmental Brain Research · 1997 · 28 citations · Full text

Medicine, Neuroscience, Pharmacology +17